Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SQI Diagnostics Inc V.SQD.H

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its... see more

TSXV:SQD.H - Post Discussion

SQI Diagnostics Inc > Just UHN and Just One Product - TOR-Dx
View:
Post by FactFinder1994 on Mar 06, 2023 10:01am

Just UHN and Just One Product - TOR-Dx

We understand that SQI's TOR-Dx test will assist in taking utalization of donor lungs from being utalized between 1-2 times in 5, to 3-4 times in 5.  
Even if in raw numbers we calculate the additional lung transplant procedures at Toronto General (UHN) and error on the low side, suggesting an additional 100 lungs can be utalized for transplant - what does this mean?  
First of all, 98 to 99 of these transplants will be deemed a sucess - saving lives.  That is HUGE.  
Secondly and $500K of profit per additional transplant, that will bring in an additional $50M annually to the hospital.  
Reminder - this is just the UHN. One Product, one Facility.
Now add all the other pieces together.  Off the map opportunity.    
There is all the incentive in the world to see things through for the benefit of all involved.  
To suggest that the Directors and Management of SQI would not do the right thing for all, and risk lives, reputation and credibility - just doesn't make sense.  These people are not morally corrupt.
Its beyond obvious to anyone that has done any real homework - The opportunity is very significant.
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities